Journal Watch
Tuesday, May 22nd, 2018Novel anti-cancer drug resistance mechanism identified Vanderbilt investigators have discovered a novel nongenetic cause of resistance to cetuximab, a mainstay of treatment for advanced colorectal cancer. The findings of Robert Coffey Jr., MD, and colleagues, published Oct. 16, 2017, in Nature Medicine, suggest a strategy for overcoming this resistance, which their research indicates is due […]